nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorhexidine—Tooth disorder—Imiquimod—skin cancer	0.0252	0.027	CcSEcCtD
Chlorhexidine—Trauma—Bleomycin—skin cancer	0.0244	0.0261	CcSEcCtD
Chlorhexidine—Ulcerative stomatitis—Dactinomycin—skin cancer	0.0235	0.0251	CcSEcCtD
Chlorhexidine—Influenza-like symptoms—Imiquimod—skin cancer	0.0229	0.0245	CcSEcCtD
Chlorhexidine—Tenderness—Imiquimod—skin cancer	0.0188	0.02	CcSEcCtD
Chlorhexidine—Ulcer—Imiquimod—skin cancer	0.0173	0.0185	CcSEcCtD
Chlorhexidine—Influenza like illness—Imiquimod—skin cancer	0.0159	0.017	CcSEcCtD
Chlorhexidine—Skin exfoliation—Imiquimod—skin cancer	0.0156	0.0167	CcSEcCtD
Chlorhexidine—Tooth disorder—Temozolomide—skin cancer	0.0151	0.0162	CcSEcCtD
Chlorhexidine—Influenza-like symptoms—Temozolomide—skin cancer	0.0137	0.0147	CcSEcCtD
Chlorhexidine—Swelling—Imiquimod—skin cancer	0.0135	0.0144	CcSEcCtD
Chlorhexidine—Tenderness—Bleomycin—skin cancer	0.0133	0.0142	CcSEcCtD
Chlorhexidine—Dysgeusia—Vismodegib—skin cancer	0.0133	0.0142	CcSEcCtD
Chlorhexidine—Back pain—Vismodegib—skin cancer	0.0131	0.014	CcSEcCtD
Chlorhexidine—Injury—Imiquimod—skin cancer	0.0129	0.0138	CcSEcCtD
Chlorhexidine—Ulcer—Bleomycin—skin cancer	0.0123	0.0131	CcSEcCtD
Chlorhexidine—Arthralgia—Vismodegib—skin cancer	0.0116	0.0124	CcSEcCtD
Chlorhexidine—Myalgia—Vismodegib—skin cancer	0.0116	0.0124	CcSEcCtD
Chlorhexidine—Ulcer—Dactinomycin—skin cancer	0.0115	0.0123	CcSEcCtD
Chlorhexidine—Skin exfoliation—Bleomycin—skin cancer	0.0111	0.0119	CcSEcCtD
Chlorhexidine—Tenderness—Fluorouracil—skin cancer	0.0104	0.0111	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.0101	0.0108	CcSEcCtD
Chlorhexidine—Bronchitis—Imiquimod—skin cancer	0.00988	0.0106	CcSEcCtD
Chlorhexidine—Mouth ulceration—Dactinomycin—skin cancer	0.00981	0.0105	CcSEcCtD
Chlorhexidine—Dyspepsia—Vismodegib—skin cancer	0.00976	0.0104	CcSEcCtD
Chlorhexidine—Redness—Docetaxel—skin cancer	0.00967	0.0103	CcSEcCtD
Chlorhexidine—Ulcer—Fluorouracil—skin cancer	0.00956	0.0102	CcSEcCtD
Chlorhexidine—Upper respiratory tract infection—Imiquimod—skin cancer	0.00955	0.0102	CcSEcCtD
Chlorhexidine—Influenza like illness—Temozolomide—skin cancer	0.00953	0.0102	CcSEcCtD
Chlorhexidine—Pain—Vismodegib—skin cancer	0.00948	0.0101	CcSEcCtD
Chlorhexidine—Burning sensation—Docetaxel—skin cancer	0.00939	0.01	CcSEcCtD
Chlorhexidine—Skin exfoliation—Temozolomide—skin cancer	0.00937	0.01	CcSEcCtD
Chlorhexidine—Injury—Bleomycin—skin cancer	0.00919	0.00981	CcSEcCtD
Chlorhexidine—Sinusitis—Imiquimod—skin cancer	0.00859	0.00918	CcSEcCtD
Chlorhexidine—Erythema—Vemurafenib—skin cancer	0.00839	0.00897	CcSEcCtD
Chlorhexidine—Rhinitis—Imiquimod—skin cancer	0.00824	0.00881	CcSEcCtD
Chlorhexidine—Dysgeusia—Vemurafenib—skin cancer	0.00822	0.00878	CcSEcCtD
Chlorhexidine—Pharyngitis—Imiquimod—skin cancer	0.00816	0.00872	CcSEcCtD
Chlorhexidine—Back pain—Vemurafenib—skin cancer	0.00812	0.00867	CcSEcCtD
Chlorhexidine—Swelling—Fluorouracil—skin cancer	0.00744	0.00795	CcSEcCtD
Chlorhexidine—Cough—Vemurafenib—skin cancer	0.00732	0.00782	CcSEcCtD
Chlorhexidine—Erythema—Imiquimod—skin cancer	0.00716	0.00765	CcSEcCtD
Chlorhexidine—Arthralgia—Vemurafenib—skin cancer	0.00715	0.00763	CcSEcCtD
Chlorhexidine—Myalgia—Vemurafenib—skin cancer	0.00715	0.00763	CcSEcCtD
Chlorhexidine—Back pain—Imiquimod—skin cancer	0.00692	0.0074	CcSEcCtD
Chlorhexidine—Anaphylactic shock—Vemurafenib—skin cancer	0.00685	0.00732	CcSEcCtD
Chlorhexidine—SLC47A2—head—skin cancer	0.00663	0.104	CbGeAlD
Chlorhexidine—HNMT—connective tissue—skin cancer	0.0066	0.104	CbGeAlD
Chlorhexidine—Osteoarthritis—Fluorouracil—skin cancer	0.00656	0.00701	CcSEcCtD
Chlorhexidine—Stomatitis—Bleomycin—skin cancer	0.00634	0.00677	CcSEcCtD
Chlorhexidine—Influenza like illness—Docetaxel—skin cancer	0.00634	0.00677	CcSEcCtD
Chlorhexidine—HNMT—epithelium—skin cancer	0.00627	0.0983	CbGeAlD
Chlorhexidine—Cough—Imiquimod—skin cancer	0.00625	0.00667	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00624	0.00667	CcSEcCtD
Chlorhexidine—Skin exfoliation—Docetaxel—skin cancer	0.00623	0.00665	CcSEcCtD
Chlorhexidine—Hypertension—Imiquimod—skin cancer	0.00618	0.0066	CcSEcCtD
Chlorhexidine—Myalgia—Imiquimod—skin cancer	0.00609	0.00651	CcSEcCtD
Chlorhexidine—Arthralgia—Imiquimod—skin cancer	0.00609	0.00651	CcSEcCtD
Chlorhexidine—Discomfort—Imiquimod—skin cancer	0.00602	0.00643	CcSEcCtD
Chlorhexidine—Dry mouth—Imiquimod—skin cancer	0.00596	0.00637	CcSEcCtD
Chlorhexidine—Bronchitis—Temozolomide—skin cancer	0.00592	0.00632	CcSEcCtD
Chlorhexidine—Stomatitis—Dactinomycin—skin cancer	0.00592	0.00632	CcSEcCtD
Chlorhexidine—Hypoaesthesia—Bleomycin—skin cancer	0.00581	0.00621	CcSEcCtD
Chlorhexidine—Upper respiratory tract infection—Temozolomide—skin cancer	0.00572	0.00611	CcSEcCtD
Chlorhexidine—SLC47A1—nipple—skin cancer	0.00556	0.0872	CbGeAlD
Chlorhexidine—Pharyngitis—Dactinomycin—skin cancer	0.00541	0.00578	CcSEcCtD
Chlorhexidine—Swelling—Docetaxel—skin cancer	0.00537	0.00574	CcSEcCtD
Chlorhexidine—Stomatitis—Temozolomide—skin cancer	0.00535	0.00571	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00532	0.00568	CcSEcCtD
Chlorhexidine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00527	0.00563	CcSEcCtD
Chlorhexidine—Paraesthesia—Imiquimod—skin cancer	0.00525	0.0056	CcSEcCtD
Chlorhexidine—Sinusitis—Temozolomide—skin cancer	0.00515	0.0055	CcSEcCtD
Chlorhexidine—Dyspepsia—Imiquimod—skin cancer	0.00514	0.00549	CcSEcCtD
Chlorhexidine—Erythema—Bleomycin—skin cancer	0.00509	0.00543	CcSEcCtD
Chlorhexidine—Hypersensitivity—Vemurafenib—skin cancer	0.00505	0.00539	CcSEcCtD
Chlorhexidine—Pain—Imiquimod—skin cancer	0.005	0.00534	CcSEcCtD
Chlorhexidine—Stomatitis—Fluorouracil—skin cancer	0.00493	0.00527	CcSEcCtD
Chlorhexidine—Hypoaesthesia—Temozolomide—skin cancer	0.0049	0.00524	CcSEcCtD
Chlorhexidine—Pharyngitis—Temozolomide—skin cancer	0.00489	0.00522	CcSEcCtD
Chlorhexidine—Sinusitis—Fluorouracil—skin cancer	0.00474	0.00507	CcSEcCtD
Chlorhexidine—Erythema—Dactinomycin—skin cancer	0.00474	0.00507	CcSEcCtD
Chlorhexidine—HNMT—female reproductive system—skin cancer	0.00466	0.073	CbGeAlD
Chlorhexidine—Urticaria—Imiquimod—skin cancer	0.00464	0.00496	CcSEcCtD
Chlorhexidine—Rhinitis—Fluorouracil—skin cancer	0.00455	0.00486	CcSEcCtD
Chlorhexidine—Hypoaesthesia—Fluorouracil—skin cancer	0.00452	0.00483	CcSEcCtD
Chlorhexidine—Pharyngitis—Fluorouracil—skin cancer	0.00451	0.00481	CcSEcCtD
Chlorhexidine—Cough—Bleomycin—skin cancer	0.00444	0.00474	CcSEcCtD
Chlorhexidine—SLC22A3—nipple—skin cancer	0.00443	0.0695	CbGeAlD
Chlorhexidine—Myalgia—Bleomycin—skin cancer	0.00433	0.00462	CcSEcCtD
Chlorhexidine—Hypersensitivity—Imiquimod—skin cancer	0.0043	0.0046	CcSEcCtD
Chlorhexidine—Headache—Vemurafenib—skin cancer	0.00429	0.00458	CcSEcCtD
Chlorhexidine—Erythema—Temozolomide—skin cancer	0.00429	0.00458	CcSEcCtD
Chlorhexidine—Discomfort—Bleomycin—skin cancer	0.00428	0.00457	CcSEcCtD
Chlorhexidine—Dysgeusia—Temozolomide—skin cancer	0.0042	0.00449	CcSEcCtD
Chlorhexidine—Anaphylactic shock—Bleomycin—skin cancer	0.00415	0.00443	CcSEcCtD
Chlorhexidine—Back pain—Temozolomide—skin cancer	0.00415	0.00443	CcSEcCtD
Chlorhexidine—Myalgia—Dactinomycin—skin cancer	0.00404	0.00431	CcSEcCtD
Chlorhexidine—Discomfort—Dactinomycin—skin cancer	0.00399	0.00426	CcSEcCtD
Chlorhexidine—Erythema—Fluorouracil—skin cancer	0.00395	0.00422	CcSEcCtD
Chlorhexidine—HNMT—head—skin cancer	0.00389	0.061	CbGeAlD
Chlorhexidine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00378	0.00404	CcSEcCtD
Chlorhexidine—Cough—Temozolomide—skin cancer	0.00374	0.004	CcSEcCtD
Chlorhexidine—Paraesthesia—Bleomycin—skin cancer	0.00373	0.00398	CcSEcCtD
Chlorhexidine—Hypertension—Temozolomide—skin cancer	0.0037	0.00396	CcSEcCtD
Chlorhexidine—Headache—Imiquimod—skin cancer	0.00366	0.00391	CcSEcCtD
Chlorhexidine—Myalgia—Temozolomide—skin cancer	0.00365	0.0039	CcSEcCtD
Chlorhexidine—Arthralgia—Temozolomide—skin cancer	0.00365	0.0039	CcSEcCtD
Chlorhexidine—Discomfort—Temozolomide—skin cancer	0.00361	0.00385	CcSEcCtD
Chlorhexidine—Dry mouth—Temozolomide—skin cancer	0.00357	0.00381	CcSEcCtD
Chlorhexidine—Stomatitis—Docetaxel—skin cancer	0.00356	0.0038	CcSEcCtD
Chlorhexidine—Pain—Bleomycin—skin cancer	0.00355	0.00379	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00353	0.00377	CcSEcCtD
Chlorhexidine—Anaphylactic shock—Temozolomide—skin cancer	0.0035	0.00374	CcSEcCtD
Chlorhexidine—Myalgia—Fluorouracil—skin cancer	0.00336	0.00359	CcSEcCtD
Chlorhexidine—Discomfort—Fluorouracil—skin cancer	0.00332	0.00355	CcSEcCtD
Chlorhexidine—Pain—Dactinomycin—skin cancer	0.00331	0.00354	CcSEcCtD
Chlorhexidine—Urticaria—Bleomycin—skin cancer	0.0033	0.00352	CcSEcCtD
Chlorhexidine—Rhinitis—Docetaxel—skin cancer	0.00329	0.00351	CcSEcCtD
Chlorhexidine—Hypoaesthesia—Docetaxel—skin cancer	0.00326	0.00348	CcSEcCtD
Chlorhexidine—Pharyngitis—Docetaxel—skin cancer	0.00325	0.00347	CcSEcCtD
Chlorhexidine—SLC47A1—mammalian vulva—skin cancer	0.00325	0.0509	CbGeAlD
Chlorhexidine—Anaphylactic shock—Fluorouracil—skin cancer	0.00323	0.00345	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00319	0.00341	CcSEcCtD
Chlorhexidine—Paraesthesia—Temozolomide—skin cancer	0.00314	0.00336	CcSEcCtD
Chlorhexidine—SLC22A3—connective tissue—skin cancer	0.00314	0.0493	CbGeAlD
Chlorhexidine—Dyspepsia—Temozolomide—skin cancer	0.00308	0.00329	CcSEcCtD
Chlorhexidine—Hypersensitivity—Bleomycin—skin cancer	0.00306	0.00327	CcSEcCtD
Chlorhexidine—Pain—Temozolomide—skin cancer	0.00299	0.0032	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00294	0.00314	CcSEcCtD
Chlorhexidine—Paraesthesia—Fluorouracil—skin cancer	0.0029	0.00309	CcSEcCtD
Chlorhexidine—Erythema—Docetaxel—skin cancer	0.00285	0.00305	CcSEcCtD
Chlorhexidine—Hypersensitivity—Dactinomycin—skin cancer	0.00285	0.00305	CcSEcCtD
Chlorhexidine—Dyspepsia—Fluorouracil—skin cancer	0.00284	0.00303	CcSEcCtD
Chlorhexidine—Dysgeusia—Docetaxel—skin cancer	0.00279	0.00298	CcSEcCtD
Chlorhexidine—Urticaria—Temozolomide—skin cancer	0.00278	0.00297	CcSEcCtD
Chlorhexidine—SLC47A1—female reproductive system—skin cancer	0.00278	0.0436	CbGeAlD
Chlorhexidine—Back pain—Docetaxel—skin cancer	0.00276	0.00295	CcSEcCtD
Chlorhexidine—Pain—Fluorouracil—skin cancer	0.00276	0.00295	CcSEcCtD
Chlorhexidine—HNMT—lymph node—skin cancer	0.00272	0.0427	CbGeAlD
Chlorhexidine—SLC22A3—mammalian vulva—skin cancer	0.00259	0.0406	CbGeAlD
Chlorhexidine—Hypersensitivity—Temozolomide—skin cancer	0.00258	0.00275	CcSEcCtD
Chlorhexidine—Urticaria—Fluorouracil—skin cancer	0.00256	0.00274	CcSEcCtD
Chlorhexidine—Cough—Docetaxel—skin cancer	0.00249	0.00266	CcSEcCtD
Chlorhexidine—Hypertension—Docetaxel—skin cancer	0.00246	0.00263	CcSEcCtD
Chlorhexidine—Myalgia—Docetaxel—skin cancer	0.00243	0.00259	CcSEcCtD
Chlorhexidine—Arthralgia—Docetaxel—skin cancer	0.00243	0.00259	CcSEcCtD
Chlorhexidine—Hypersensitivity—Fluorouracil—skin cancer	0.00238	0.00254	CcSEcCtD
Chlorhexidine—Dry mouth—Docetaxel—skin cancer	0.00238	0.00254	CcSEcCtD
Chlorhexidine—Anaphylactic shock—Docetaxel—skin cancer	0.00233	0.00249	CcSEcCtD
Chlorhexidine—SLC47A1—head—skin cancer	0.00232	0.0364	CbGeAlD
Chlorhexidine—SLC22A3—female reproductive system—skin cancer	0.00222	0.0348	CbGeAlD
Chlorhexidine—Headache—Temozolomide—skin cancer	0.00219	0.00234	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00212	0.00227	CcSEcCtD
Chlorhexidine—Paraesthesia—Docetaxel—skin cancer	0.00209	0.00223	CcSEcCtD
Chlorhexidine—Dyspepsia—Docetaxel—skin cancer	0.00205	0.00219	CcSEcCtD
Chlorhexidine—Headache—Fluorouracil—skin cancer	0.00202	0.00216	CcSEcCtD
Chlorhexidine—Pain—Docetaxel—skin cancer	0.00199	0.00213	CcSEcCtD
Chlorhexidine—SLC22A1—head—skin cancer	0.00194	0.0304	CbGeAlD
Chlorhexidine—SLC22A3—head—skin cancer	0.00185	0.029	CbGeAlD
Chlorhexidine—Hypersensitivity—Docetaxel—skin cancer	0.00172	0.00183	CcSEcCtD
Chlorhexidine—SLC47A1—lymph node—skin cancer	0.00163	0.0255	CbGeAlD
Chlorhexidine—Headache—Docetaxel—skin cancer	0.00146	0.00156	CcSEcCtD
Chlorhexidine—SLC22A3—lymph node—skin cancer	0.0013	0.0203	CbGeAlD
